EVT

Evotec
EVT

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€1.33B
EV
€1.38B
Shares Outstanding
177.60M
Beta
1.09

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€11.80
P/E 2025E
-
P/Revenue 2025E
1.53x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Evotec SE

gainify
EVT

Evotec SE

EVT

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibro...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Wojczewski, Christian

Employees

4,740

IPO Date

1999-11-12

Headquarters

Essener Bogen 7, Hamburg, Hamburg, 22419, Germany

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved